TITLE

Imatinib Mesylate-Induced Interstitial Pneumonitis

AUTHOR(S)
Ma, Cynthia X.; Hobday, Timothy J.; Jett, James R.
PUB. DATE
December 2003
SOURCE
Mayo Clinic Proceedings;Dec2003, Vol. 78 Issue 12, p1578
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a letter to the editor about a case of imatinib-induced interstitial pneumonitis that was treated successfully with prednisone.
ACCESSION #
11579113

 

Related Articles

  • A Variant in the Promoter of MUC5B and Idiopathic Pulmonary Fibrosis. Yingze Zhang; Noth, Imre; Garcia, Joe G. N.; Kaminski, Naftali // New England Journal of Medicine;4/21/2011, Vol. 364 Issue 16, p1576 

    A letter to the editor is presented in response to idiopathic pulmonary fibrosis as a genetic disease, and research confirming such.

  • Centrilobular emphysema combined with pulmonary fibrosis results in improved survival: a response.  // Fibrogenesis & Tissue Repair;2011, Vol. 4 Issue 1, p16 

    A letter to the editor is presented in response to the article "Centrilobular emphysema combined with pulmonary fibrosis results in improved survival," by N. W. Todd, and colleagues, in the previous issue.

  • Survival in pulmonary fibrosis combined with emphysema: likely defined by characteristics of specific patient subpopulations.  // Fibrogenesis & Tissue Repair;2011, Vol. 4 Issue 1, p17 

    A response by Nevins W. Todd, and Sergei P. Atamas, to a letter to the editor about his article "Centrilobular emphysema combined with pulmonary fibrosis results in improved survival," in the previous issue is presented.

  • Acetylcysteine in Pulmonary Fibrosis. Hull, James H.K. // New England Journal of Medicine;3/9/2006, Vol. 354 Issue 10, p1089 

    A letter to the editor is presented in response to a study on acetylcysteine treatment in pulmonary fibrosis by researcher Maurits Demedts and colleagues in the November 24, 2005 issue.

  • Acetylcysteine in Pulmonary Fibrosis. Toma, Tudor P.; Bhowmik, Angshu; Rajakulasingam, Raja // New England Journal of Medicine;3/9/2006, Vol. 354 Issue 10, p1089 

    A letter to the editor is presented in response to a study on acetylcysteine treatment in pulmonary fibrosis by researcher Maurits Demedts and colleagues in the November 24, 2005 issue.

  • Acetylcysteine in Pulmonary Fibrosis. Demedts, Maurits; Buhl, Roland; Costabel, Ulrich // New England Journal of Medicine;3/9/2006, Vol. 354 Issue 10, p1089 

    A response by researcher Maurits Demedts and his colleagues to letters to the editor about their article on acetylcysteine treatment in pulmonary fibrosis in the November 24, 2005 issue is presented.

  • Case 32-2001: Interstitial Pneumonitis and Rheumatoid Arthritis. Golden, Harvey E. // New England Journal of Medicine;3/14/2002, Vol. 346 Issue 11, p866 

    A letter to the editor is presented related to a case of interstitial pneumonitis and rheumatoid arthritis published in the October 18, 2001 issue.

  • Thalidomide inhibits the intractable cough of idiopathic pulmonary fibrosis. Horton, M. R.; Danoff, S. K.; Lechtzin, N. // Thorax;Aug2008, Vol. 63 Issue 8, p749 

    A letter to the editor is presented describing the resolution of idiopathic pulmonary fibrosis (IPF) associated chronic cough with thalidomide in 10 patients with IPF.

  • Acute Exacerbations in Idiopathic Pulmonary Fibrosis. Crowley, Searnus P.; Kelly, Peter; Egan, Jim J. // Annals of Internal Medicine;2/7/2006, Vol. 144 Issue 3, p218 

    A letter to the editor is presented commenting on the treatment of patients with idiopathic pulmonary fibrosis.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics